Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...

Our policy briefings and explainers are part of our horizon-scanning programme to identify those novel technologies showing greatest promise for health research and care. Succinct and accessible, they ...

PHG Foundation We are an exempt charity under the Charities Act 2011 and regulated by the Office for Students (OFS) as a connected institution of the University of Cambridge. We are also a registered ...

Chantal is a Senior Policy Analyst contributing to many of PHG foundations projects including B-CAST, polygenic scores and Innovative Science. As a senior analyst she supports the science team in ...

AI and its potential impact on genomics research and clinical practice was peppered throughout this year's Festival of Genomics ...

This report outlines the case for further guidance and related support to healthcare professionals to maximise the possibility of genomic information being shared with all relevant family members.

In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make ...

Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...

Laura is PHG Foundation’s Head of Science, and is responsible for the delivery of the scientific expertise and analysis that underpin our work. She also contributes to the development of our strategic ...

‘While molecular biomarkers such as genetics have proved valuable in the management of many diseases, the dynamic information provided by many physiological biomarkers will complement, enhance and ...